Skip Navigation


NDT Advance Access originally published online on December 7, 2005
Nephrology Dialysis Transplantation 2006 21(3):665-671; doi:10.1093/ndt/gfi312
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/3/665    most recent
gfi312v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Longo, I.
Right arrow Articles by Meloni, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Longo, I.
Right arrow Articles by Meloni, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Clinical Nephrology

Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families

Ilaria Longo1, Elisa Scala1, Francesca Mari1, Rossella Caselli1, Chiara Pescucci1, Maria Antonietta Mencarelli1, Caterina Speciale1, Marisa Giani2, Elena Bresin3, Domenica Angela Caringella4, Zvi-Uri Borochowitz5, Komudi Siriwardena6, Ingrid Winship6, Alessandra Renieri1 and Ilaria Meloni1

1 Medical Genetics, Department of Molecular Biology, University of Siena, 2 Clinica Pediatrica "G. e D. De Marchi", University of Milano, 3 Centro Ricerche Cliniche Malattie Rare, Villa Camozzi Ranica, Bergamo and 4 Dipartimento di Medicina Pediatrica, Ospedale Regionale Pediatrico Giovanni XXIII, Bari, Italy, 5 Simon Winter Institute for Human Genetics, Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine, Haifa, Israel and 6 Northern Regional Genetic Service, Auckland Hospital, New Zealand

Correspondence and offprint requests to: Alessandra Renieri, MD, PhD, Associate Professor, Medical Genetics, University of Siena, Policlinico "S.Maria alle Scotte", V.le Bracci 2, 53100 Siena, Italy. Email: renieri{at}unisi.it

Background. Alport syndrome (ATS) is a progressive inherited nephropathy characterized by irregular thinning, thickening and splitting of the glomerular basement membrane (GBM) often associated with hearing loss and ocular symptoms. ATS has been shown to be caused by COL4A5 mutations in its X-linked form and by COL4A3 and COL4A4 mutations in its autosomal forms.

Methods. Five families with a suspicion of ATS were investigated both from a clinical and molecular point of view. COL4A3 and COL4A4 genes were analysed by DHPLC. Automated sequencing was performed to identify the underlying mutation.

Results. Molecular analysis indicated that in all 5 cases the correct diagnosis was autosomal recessive ATS. In three families in which parental consanguinity clearly pinpointed to autosomal recessive ATS, we found COL4A4 homozygous mutations in two of them and COL4A3 homozygous mutation in the other one. In the remaining two families a differential diagnosis including X-linked ATS, autosomal recessive ATS and thin basement membrane nephropathy was considered. The molecular analysis demonstrated that the probands were genetic compounds for two different mutations in the COL4A4 gene pinpointing to the correct diagnosis of autosomal recessive ATS.

Conclusions. A clinical evaluation of probands and their relatives of the five families carrying mutations in either the COL4A3 or the COL4A4 gene was carried out to underline the natural history of the autosomal recessive ATS. In addition, this paper stresses the complexity of the clinics and genetics of ATS and how a correct diagnosis is based on a combination of: (i) an in-depth clinical investigation; (ii) a detailed formal genetic analysis; (iii) a correct technical choice of the gene to be investigated; (iv) a correct technical choice of the family member to be included in the mutational screening. A correct diagnosis is the basis for an appropriate genetic counselling dealing with both the correct prognosis and the accurate recurrence risk for the patients and family members.

Keywords: autosomal recessive ATS; collagen IV genes; DHPLC; inherited nephropathy; phenotypic variability


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Pierides, K. Voskarides, Y. Athanasiou, K. Ioannou, L. Damianou, M. Arsali, M. Zavros, M. Pierides, V. Vargemezis, C. Patsias, et al.
Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2721 - 2729.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Marcocci, V. Uliana, M. Bruttini, R. Artuso, M. C. Silengo, M. Zerial, F. Bergesio, A. Amoroso, S. Savoldi, M. Pennesi, et al.
Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1464 - 1471.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.